FDA Approves New Oral Drugs for Gonorrhoea Treatment
Photo by National Institute of Allergy and Infectious Diseases
त्वरित संशोधन
FDA approved two new oral drugs for gonorrhoea treatment: Nuzolvence and Blujepa.
Gonorrhoea is increasingly resistant to existing drugs.
Dr. Reddy's seeking market authorization for one drug in Thailand and South Africa.
महत्वपूर्ण तिथियां
महत्वपूर्ण संख्याएं
दृश्य सामग्री
Gonorrhoea Treatment Advancements
Key statistics and context surrounding the FDA approval of new gonorrhoea treatments.
- New Drugs Approved
- 2
- Global Gonorrhoea Cases (WHO est.)
- >82 million annually
- Dr. Reddy's Market Authorization
- Thailand & South Africa
FDA approval of Nuzolvence and Blujepa offers crucial alternatives to combatting antimicrobial resistance in gonorrhoea treatment.
High prevalence underscores the urgent need for new treatment options and public health interventions.
Indicates potential for wider access to these drugs in regions with high gonorrhoea prevalence.
परीक्षा के दृष्टिकोण
Public health implications of STIs
Government programs for disease control
Ethical considerations in healthcare access
विस्तृत सारांश देखें
सारांश
पृष्ठभूमि
नवीनतम घटनाक्रम
बहुविकल्पीय प्रश्न (MCQ)
1. Consider the following statements regarding Gonorrhoea: 1. It is caused by the bacterium *Neisseria gonorrhoeae*. 2. Untreated Gonorrhoea can lead to infertility. 3. The recent FDA-approved drugs, Nuzolvence and Blujepa, are the first oral medications developed for Gonorrhoea treatment. Which of the statements given above is/are correct?
- A.1 and 2 only
- B.2 and 3 only
- C.1 and 3 only
- D.1, 2 and 3
उत्तर देखें
सही उत्तर: A
Statements 1 and 2 are correct. While Nuzolvence and Blujepa are newly approved, they are not necessarily the *first* oral medications ever developed for Gonorrhoea treatment, though they are significant due to addressing antibiotic resistance.
2. In the context of rising antibiotic resistance, which of the following statements is NOT correct regarding the implications for public health?
- A.Increased healthcare costs due to longer treatment durations and the need for more expensive drugs.
- B.Higher mortality rates from previously treatable infections.
- C.Reduced need for investment in research and development of new antimicrobial agents.
- D.Greater reliance on preventive measures, such as vaccination and improved sanitation.
उत्तर देखें
सही उत्तर: C
Antibiotic resistance necessitates *increased*, not reduced, investment in research and development of new antimicrobial agents.
3. Consider the following statements regarding the role of the World Health Organization (WHO) in combating sexually transmitted infections (STIs): 1. WHO develops global strategies and guidelines for STI prevention and control. 2. WHO provides direct financial assistance to countries for STI treatment programs. 3. WHO monitors global trends in STI prevalence and antibiotic resistance. Which of the statements given above is/are correct?
- A.1 and 2 only
- B.2 and 3 only
- C.1 and 3 only
- D.1, 2 and 3
उत्तर देखें
सही उत्तर: C
WHO develops strategies and monitors trends, but its direct financial assistance is limited; it primarily facilitates funding through partnerships.
4. Assertion (A): The rise in antibiotic-resistant strains of *Neisseria gonorrhoeae* poses a significant threat to global public health. Reason (R): Overuse and misuse of antibiotics have contributed to the selection and spread of resistant bacteria. In the context of the above statements, which of the following is correct?
- A.Both A and R are true, and R is the correct explanation of A.
- B.Both A and R are true, but R is NOT the correct explanation of A.
- C.A is true, but R is false.
- D.A is false, but R is true.
उत्तर देखें
सही उत्तर: A
Both the assertion and the reason are true, and the reason correctly explains why antibiotic resistance is a threat.